LDL-C Targets in Secondary Prevention: How Low Should We Go?

LDL-C Targets in Secondary Prevention: How Low Should We Go?

<h3>Abstract</h3><p dir="ltr">The benefits of lowering low-density lipoprotein cholesterol (LDL-C), mainly using high-intensity statin therapy, and its impact on decreasing the recurrence of atherosclerotic cardiovascular disease (ASCVD) in secondary prevention has been w...

Full description

Saved in:
Bibliographic Details
Main Author: Karim Bayoumy (3496688) (author)
Other Authors: Mohammed Gaber (14151942) (author), Preethi Mani (14151945) (author), Rishi Puri (6090599) (author), Eoin Donnellan (12122073) (author), Leslie Cho (8859803) (author), Donald Clark (14151948) (author), Seth S. Martin (8164878) (author), Mohamed B. Elshazly (14151951) (author)
Published: 2019
Subjects:
Biomedical and clinical sciences
Cardiovascular medicine and haematology
Pharmacology and pharmaceutical sciences
Clinical guidelines
LDL lowering
Secondary prevention
PCSK9 inhibitors
Adverse effects
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items